Terapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados.

68 Páginas.

Autores:: Vélez Álvarez, Carlos Alfonso
Santacruz Herrera, Carlos Andrés

Tipo de recurso:

Fecha de publicación:: 2012

Institución:: Universidad de la Sabana

Repositorio:: Repositorio Universidad de la Sabana

Idioma:: spa

id	REPOUSABA2_aaaaea411e20d1970694e53a3b8cdad0
oai_identifier_str	oai:intellectum.unisabana.edu.co:10818/6365
network_acronym_str	REPOUSABA2
network_name_str	Repositorio Universidad de la Sabana
repository_id_str
dc.title.es_CO.fl_str_mv	Terapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados.
title	Terapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados.
spellingShingle	Terapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados. Aparato respiratorio-Enfermedades Terapia respiratoria Farmacología
title_short	Terapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados.
title_full	Terapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados.
title_fullStr	Terapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados.
title_full_unstemmed	Terapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados.
title_sort	Terapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados.
dc.creator.fl_str_mv	Vélez Álvarez, Carlos Alfonso Santacruz Herrera, Carlos Andrés
dc.contributor.advisor.none.fl_str_mv	Oliveros Rodríguez, Henry
dc.contributor.author.none.fl_str_mv	Vélez Álvarez, Carlos Alfonso Santacruz Herrera, Carlos Andrés
dc.subject.es_CO.fl_str_mv	Aparato respiratorio-Enfermedades Terapia respiratoria Farmacología
topic	Aparato respiratorio-Enfermedades Terapia respiratoria Farmacología
description	68 Páginas.
publishDate	2012
dc.date.created.none.fl_str_mv	2012
dc.date.accessioned.none.fl_str_mv	2013-03-08T21:33:02Z
dc.date.available.none.fl_str_mv	2013-03-08T21:33:02Z
dc.date.issued.none.fl_str_mv	2013-03-08
dc.type.none.fl_str_mv	bachelorThesis
dc.type.coarversion.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_7a1f
dc.type.local.none.fl_str_mv	Tesis de especialización
dc.type.hasVersion.none.fl_str_mv	publishedVersion
dc.identifier.citation.none.fl_str_mv	Ashbaugh D, Bigelow D, Petty T, Levine BE. Acute respiratory distress in Adults. Lancet 1967; 290: 319 - 323. Petty T, Ashbaugh D. The Adult Respiratory Distress Syndrome: Clinical Features, Factors Influencing Prognosis and Principles of Management. Chest 1971; 60; 233 - 239. Bernard G, Artigas A, Brigham K, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818 – 824. . Brun-Buisson C, Minelli C, Lemaire F, et al. Epidemiology and outcome of acute lung injury in European intensive care units: Results from the ALIVE study. Intensive Care Med 2004; 30: 51 – 61. Phua J, Ferguson N, et al. Has Mortality from Acute Respiratory Distress Syndrome Decreased Over Time? A Systematic Review. AJRCCM Articles in Press. Am J Respir Crit Care Med 2010 Bernard G, Artigas A, Brigham K, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818 - 824 Murray J, Matthay M, Luce L, et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Res Dis 1988; 139: 720 – 723. Ranieri V, Rubenfeld G, Thompson B, et al. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012; 307 (23): 2526 – 2533 Vincent J, Zambon M. Why do patients who have acute lung Injury/Acute Respiratory Distress Syndrome die from Multiple Organ Dysfunction Syndrome? Implications for Management. Clin Chest Med 2006; 27: 725 – 731. Ware L, Matthay M. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334 - 1349. Wheeler A, Bernard G. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007; 369: 1553 - 1564 The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus Lower Positive End - Expiratory Pressures in patients with the Acute Respiratory Distress Syndrome. N Engl J Med 2004; 351: 327 - 36 Briel M, Meade M, Mercat A, et al. Higher vs. lower positive end-expiratory pressure in patients with Acute Lung Injury and Acute Respiratory Distress Syndrome. Systematic Review and Meta-analysis. JAMA 2010; 303 (9): 865 - 873. The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301 - 1308. Papazian L, Forel J, Gacouin A, et al. Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome. N Engl J Med 2010; 363: 1107 – 1116. Shariatpanahi Z, Taleban F, Mokhtari M, et al. Ginger extract reduces delayed gastric emptying and nosocomial pneumonia in adult respiratory distress syndrome patients hospitalized in an intensive care unit. J Crit Care 2010; 25 (4): 647 - 50 Raoof S, Goulet K, Esan A, et al. Severe Hypoxemic Respiratory Failure Part 2. Nonventilatory Strategies. Chest 2010; 137 (6): 1437 - 1448. Ng Gong M. Genetic epidemiology of Acute Respiratory Distress Syndrome: Implications for future prevention and treatment. Clin Chest Med. 2006 December; 27(4): 705 – x. . Reddy A, Kleeberger S. Genetic polymorphisms associated with acute lung injury. Pharmacogenomics. 2009 September; 10 (9): 1527 – 1539 . Adhikari N, Burns K, Meade M O, et al. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 10, Art. No. CD004477. Gadek J, DeMichelle S, Karlstad M, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine 1999; 27 (8): 1409 - 20. Singer P, Theilla M, Fisher H, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006; 34: 1033 - 1038. Pontes-Arruda A, DeMichele S, Seth A, et al. The Use of an inflammationmodulating diet in patients with Acute Lung Injury or Acute Respiratory Distress Syndrome: A Meta-analysis of Outcome data. JPEN J Parenter Enteral Nutr 2008; 32: 596 Rice T, Wheeler A, Thompson B, et al. Enteral Omega-3 Fatty Acid, gamma- Linolenic Acid,and antioxidant supplementation in Acute Lung Injury. JAMA. 2011; 306 (14): 1574 - 1581. Perkins G, McAuley D, Thickett D, et al. The B -Agonist Lung Injury Trial (BALTI). A Randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006; 173: 281 – 287. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Randomized, placebo-controlled clinical trial of an aerosolized b 2-Agonist for treatment of Acute Lung Injury. Am J Respir Crit Care Med 2011; 184: 561 – 568. Smith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet. 2012 January; 379: 229 – 235Smith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, ranSmith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet. 2012 January; 379: 229 – 235domised controlled trial. Lancet. 2012 January; 379: 229 – 235 Smith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet. 2012 January; 379: 229 – 235 Sud S, Friedrich J, Taccon P, et al. Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med 2010; 36: 585 – 599. Abroug F, Ouanes L, Dachraoui F, et al. An updated study-level metaanalysis of randomized controlled trials on proning in ARDS and acute lung injury. Critical Care 2011; 15: R6 Jadad A, Moore R, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled clinical trials. 1996; 17 (1): 1 – 12 Meduri U, Golden E, Freire A, et al. Methylprednisolone infusion in early severe ARDS. Results of a randomized controlled trial. Chest 2007; 131; 954 - 963 Steinberg K, Hudson L, Goodman R, et al. Efficacy and safety of Corticosteroids for persistent Acute Respiratory Distress Syndrome. N Engl J Med 2006; 354: 1671 - 84. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired Pneumonia. A preliminary randomized study. Am J Respir Crit Care Med. 2005; 171: 242 – 248 Meduri U, Headley A, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving Acute Respiratory Distress Syndrome: a randomized controlled trial. JAMA. 1998; 280 (2): 159 - 65 Olivo S, Macedo L, Gadotti I et al. Scales to asses the quality of randomized controlled Trials: A systematic review. Phisycal Therapy. 2008; 88 (2). Taylor R, Zimmerman J, Dellinger R, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004; 291 (13): 1603 – 9. Dellinger R, Zimmerman J, Taylor R, et al. Effects of inhaled nitric oxide in patients with Acute Respiratory Distress Syndrome: Results of a randomized phase II trial. Crit Care Med 1998 Jan; 26 (1): 15 - 23. Troncy E, Collet J, Shapiro S, et al. Inhaled nitric oxide in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 1998; 157: 1483 – 1488 Michael J, Barton R, Saffle J, et al. Inhaled nitric oxide versus conventional therapy effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998; 157: 1372 – 1380. Payen D, Vallet B, for the Genoa group. Results of the French prospective multicentric randomized double-blind placebo-controlled trial on inhaled nitric oxide in A RDS [abstract]. Int Care Med. 1999; 25 Sl 1: 83. Mehta S, Simms H, Levy M, et al. Inhaled nitric oxide improves oxygenation acutely but not chronically in acute respiratory distress syndrome: a randomized, controlled trial. Journal of applied research in clinical and experimental therapeutics 2001; 1: 73 – 84. Park K, Lee Y, Oh Y, et al. Combined effects of inhaled nitric oxide and a recruitment maneuver in patients with Acute Respiratory Distress Syndrome. Yonsei Medical Journal 2003; 44 (2): 219 – 26. Lundin S, Mang H, Smithies M, et al. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. Int Care Med. 1999; 25: 911 – 9. Gerlach H, Keh D, Semmerow A, et al. Dose-response characteristics during long -term inhalation of nitric oxide in patients with severe Acute Respiratory Distress Syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med 2003; 167 (7): 1008 – 15. Cuthbertson B, Galley H, Webster N. Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury. Crit Care Med 2000; 28: 1736 – 41. Afshari A, Brok J, Møller A, et al. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No. CD002787. Cinel I, Opal S. Molecular biology of inflammation and sepsis: A primer. Crit Care Med 2009; 37: 291 – 304. Vincent J, Artigas A, Petersen L, et al. A multicenter, randomized, doubleblind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome. Crit Care Med. 2009: 37; 1874 – 1880. Liu K, Levitt J, Zhuo H, et al. Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury. Am J Respir Crit Care Med. 2008; 178; 618 – 623. Montgomery B, Stager M, Carrico J, et al. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985; 132: 485 – 91 The national heart, blood and lung institute Acute Respiratory Distress Syndrome (ARDS) clinical trials network. Comparison of two fluidmanagement strategies in acute lung injury. N Engl J Med. 2006; 354: 2564 - 75. Ferring M, Vincent J. Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J. 1997; 10: 1297 – 300 Estenssoro E, Dubin A, Laffaire E, et al. Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med 2002; 30: 2450 – 6 Peter J, John P, Graham P, et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: metaanalysis. BMJ. 2008; 336; 1006 – 09 Tang B, Craig J, Eslick G, et al. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and metaanalysis. Crit Care Med. 2009; 37: 1594 – 1603.
dc.identifier.uri.none.fl_str_mv	http://hdl.handle.net/10818/6365
dc.identifier.local.none.fl_str_mv	159385 TE05794
identifier_str_mv	Ashbaugh D, Bigelow D, Petty T, Levine BE. Acute respiratory distress in Adults. Lancet 1967; 290: 319 - 323. Petty T, Ashbaugh D. The Adult Respiratory Distress Syndrome: Clinical Features, Factors Influencing Prognosis and Principles of Management. Chest 1971; 60; 233 - 239. Bernard G, Artigas A, Brigham K, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818 – 824. . Brun-Buisson C, Minelli C, Lemaire F, et al. Epidemiology and outcome of acute lung injury in European intensive care units: Results from the ALIVE study. Intensive Care Med 2004; 30: 51 – 61. Phua J, Ferguson N, et al. Has Mortality from Acute Respiratory Distress Syndrome Decreased Over Time? A Systematic Review. AJRCCM Articles in Press. Am J Respir Crit Care Med 2010 Bernard G, Artigas A, Brigham K, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818 - 824 Murray J, Matthay M, Luce L, et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Res Dis 1988; 139: 720 – 723. Ranieri V, Rubenfeld G, Thompson B, et al. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012; 307 (23): 2526 – 2533 Vincent J, Zambon M. Why do patients who have acute lung Injury/Acute Respiratory Distress Syndrome die from Multiple Organ Dysfunction Syndrome? Implications for Management. Clin Chest Med 2006; 27: 725 – 731. Ware L, Matthay M. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334 - 1349. Wheeler A, Bernard G. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007; 369: 1553 - 1564 The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus Lower Positive End - Expiratory Pressures in patients with the Acute Respiratory Distress Syndrome. N Engl J Med 2004; 351: 327 - 36 Briel M, Meade M, Mercat A, et al. Higher vs. lower positive end-expiratory pressure in patients with Acute Lung Injury and Acute Respiratory Distress Syndrome. Systematic Review and Meta-analysis. JAMA 2010; 303 (9): 865 - 873. The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301 - 1308. Papazian L, Forel J, Gacouin A, et al. Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome. N Engl J Med 2010; 363: 1107 – 1116. Shariatpanahi Z, Taleban F, Mokhtari M, et al. Ginger extract reduces delayed gastric emptying and nosocomial pneumonia in adult respiratory distress syndrome patients hospitalized in an intensive care unit. J Crit Care 2010; 25 (4): 647 - 50 Raoof S, Goulet K, Esan A, et al. Severe Hypoxemic Respiratory Failure Part 2. Nonventilatory Strategies. Chest 2010; 137 (6): 1437 - 1448. Ng Gong M. Genetic epidemiology of Acute Respiratory Distress Syndrome: Implications for future prevention and treatment. Clin Chest Med. 2006 December; 27(4): 705 – x. . Reddy A, Kleeberger S. Genetic polymorphisms associated with acute lung injury. Pharmacogenomics. 2009 September; 10 (9): 1527 – 1539 . Adhikari N, Burns K, Meade M O, et al. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 10, Art. No. CD004477. Gadek J, DeMichelle S, Karlstad M, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine 1999; 27 (8): 1409 - 20. Singer P, Theilla M, Fisher H, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006; 34: 1033 - 1038. Pontes-Arruda A, DeMichele S, Seth A, et al. The Use of an inflammationmodulating diet in patients with Acute Lung Injury or Acute Respiratory Distress Syndrome: A Meta-analysis of Outcome data. JPEN J Parenter Enteral Nutr 2008; 32: 596 Rice T, Wheeler A, Thompson B, et al. Enteral Omega-3 Fatty Acid, gamma- Linolenic Acid,and antioxidant supplementation in Acute Lung Injury. JAMA. 2011; 306 (14): 1574 - 1581. Perkins G, McAuley D, Thickett D, et al. The B -Agonist Lung Injury Trial (BALTI). A Randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006; 173: 281 – 287. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Randomized, placebo-controlled clinical trial of an aerosolized b 2-Agonist for treatment of Acute Lung Injury. Am J Respir Crit Care Med 2011; 184: 561 – 568. Smith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet. 2012 January; 379: 229 – 235Smith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, ranSmith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet. 2012 January; 379: 229 – 235domised controlled trial. Lancet. 2012 January; 379: 229 – 235 Smith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet. 2012 January; 379: 229 – 235 Sud S, Friedrich J, Taccon P, et al. Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med 2010; 36: 585 – 599. Abroug F, Ouanes L, Dachraoui F, et al. An updated study-level metaanalysis of randomized controlled trials on proning in ARDS and acute lung injury. Critical Care 2011; 15: R6 Jadad A, Moore R, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled clinical trials. 1996; 17 (1): 1 – 12 Meduri U, Golden E, Freire A, et al. Methylprednisolone infusion in early severe ARDS. Results of a randomized controlled trial. Chest 2007; 131; 954 - 963 Steinberg K, Hudson L, Goodman R, et al. Efficacy and safety of Corticosteroids for persistent Acute Respiratory Distress Syndrome. N Engl J Med 2006; 354: 1671 - 84. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired Pneumonia. A preliminary randomized study. Am J Respir Crit Care Med. 2005; 171: 242 – 248 Meduri U, Headley A, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving Acute Respiratory Distress Syndrome: a randomized controlled trial. JAMA. 1998; 280 (2): 159 - 65 Olivo S, Macedo L, Gadotti I et al. Scales to asses the quality of randomized controlled Trials: A systematic review. Phisycal Therapy. 2008; 88 (2). Taylor R, Zimmerman J, Dellinger R, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004; 291 (13): 1603 – 9. Dellinger R, Zimmerman J, Taylor R, et al. Effects of inhaled nitric oxide in patients with Acute Respiratory Distress Syndrome: Results of a randomized phase II trial. Crit Care Med 1998 Jan; 26 (1): 15 - 23. Troncy E, Collet J, Shapiro S, et al. Inhaled nitric oxide in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 1998; 157: 1483 – 1488 Michael J, Barton R, Saffle J, et al. Inhaled nitric oxide versus conventional therapy effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998; 157: 1372 – 1380. Payen D, Vallet B, for the Genoa group. Results of the French prospective multicentric randomized double-blind placebo-controlled trial on inhaled nitric oxide in A RDS [abstract]. Int Care Med. 1999; 25 Sl 1: 83. Mehta S, Simms H, Levy M, et al. Inhaled nitric oxide improves oxygenation acutely but not chronically in acute respiratory distress syndrome: a randomized, controlled trial. Journal of applied research in clinical and experimental therapeutics 2001; 1: 73 – 84. Park K, Lee Y, Oh Y, et al. Combined effects of inhaled nitric oxide and a recruitment maneuver in patients with Acute Respiratory Distress Syndrome. Yonsei Medical Journal 2003; 44 (2): 219 – 26. Lundin S, Mang H, Smithies M, et al. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. Int Care Med. 1999; 25: 911 – 9. Gerlach H, Keh D, Semmerow A, et al. Dose-response characteristics during long -term inhalation of nitric oxide in patients with severe Acute Respiratory Distress Syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med 2003; 167 (7): 1008 – 15. Cuthbertson B, Galley H, Webster N. Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury. Crit Care Med 2000; 28: 1736 – 41. Afshari A, Brok J, Møller A, et al. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No. CD002787. Cinel I, Opal S. Molecular biology of inflammation and sepsis: A primer. Crit Care Med 2009; 37: 291 – 304. Vincent J, Artigas A, Petersen L, et al. A multicenter, randomized, doubleblind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome. Crit Care Med. 2009: 37; 1874 – 1880. Liu K, Levitt J, Zhuo H, et al. Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury. Am J Respir Crit Care Med. 2008; 178; 618 – 623. Montgomery B, Stager M, Carrico J, et al. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985; 132: 485 – 91 The national heart, blood and lung institute Acute Respiratory Distress Syndrome (ARDS) clinical trials network. Comparison of two fluidmanagement strategies in acute lung injury. N Engl J Med. 2006; 354: 2564 - 75. Ferring M, Vincent J. Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J. 1997; 10: 1297 – 300 Estenssoro E, Dubin A, Laffaire E, et al. Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med 2002; 30: 2450 – 6 Peter J, John P, Graham P, et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: metaanalysis. BMJ. 2008; 336; 1006 – 09 Tang B, Craig J, Eslick G, et al. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and metaanalysis. Crit Care Med. 2009; 37: 1594 – 1603. 159385 TE05794
url	http://hdl.handle.net/10818/6365
dc.language.iso.es_CO.fl_str_mv	spa
language	spa
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	http://purl.org/coar/access_right/c_abf2
dc.publisher.none.fl_str_mv	Universidad de La Sabana
dc.publisher.program.none.fl_str_mv	Especialización en Medicina Interna
dc.publisher.department.none.fl_str_mv	Facultad de Medicina
publisher.none.fl_str_mv	Universidad de La Sabana
dc.source.none.fl_str_mv	Universidad de La Sabana Intellectum Repositorio Universidad de La Sabana
institution	Universidad de la Sabana
bitstream.url.fl_str_mv	https://intellectum.unisabana.edu.co/bitstream/10818/6365/2/license.txt https://intellectum.unisabana.edu.co/bitstream/10818/6365/5/Carlos%20Alfonso%20V%c3%a9lez%20%c3%81lvarez%20%28Carta%29.pdf https://intellectum.unisabana.edu.co/bitstream/10818/6365/3/CARLOS%20ALFONSO%20VELEZ%20%28T%29FINAL.pdf https://intellectum.unisabana.edu.co/bitstream/10818/6365/4/CARLOS%20ALFONSO%20VELEZ%20%28T%29FINAL.pdf.txt
bitstream.checksum.fl_str_mv	f52a2cfd4df262e08e9b300d62c85cab 8603a5933485b845587bf14732a565ae 634edc3fe42712308d3a9eb777d7f93f 17bb03d156e9130ba507d1851a2d3bde
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5 MD5
repository.name.fl_str_mv	Intellectum Universidad de la Sabana
repository.mail.fl_str_mv	contactointellectum@unisabana.edu.co
_version_	1811952222872797184
spelling	Oliveros Rodríguez, HenryVélez Álvarez, Carlos AlfonsoSantacruz Herrera, Carlos AndrésEspecialista en Medicina Interna2013-03-08T21:33:02Z2013-03-08T21:33:02Z20122013-03-08Ashbaugh D, Bigelow D, Petty T, Levine BE. Acute respiratory distress in Adults. Lancet 1967; 290: 319 - 323.Petty T, Ashbaugh D. The Adult Respiratory Distress Syndrome: Clinical Features, Factors Influencing Prognosis and Principles of Management. Chest 1971; 60; 233 - 239.Bernard G, Artigas A, Brigham K, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818 – 824.. Brun-Buisson C, Minelli C, Lemaire F, et al. Epidemiology and outcome of acute lung injury in European intensive care units: Results from the ALIVE study. Intensive Care Med 2004; 30: 51 – 61.Phua J, Ferguson N, et al. Has Mortality from Acute Respiratory Distress Syndrome Decreased Over Time? A Systematic Review. AJRCCM Articles in Press. Am J Respir Crit Care Med 2010Bernard G, Artigas A, Brigham K, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818 - 824Murray J, Matthay M, Luce L, et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Res Dis 1988; 139: 720 – 723.Ranieri V, Rubenfeld G, Thompson B, et al. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012; 307 (23): 2526 – 2533Vincent J, Zambon M. Why do patients who have acute lung Injury/Acute Respiratory Distress Syndrome die from Multiple Organ Dysfunction Syndrome? Implications for Management. Clin Chest Med 2006; 27: 725 – 731.Ware L, Matthay M. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334 - 1349.Wheeler A, Bernard G. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007; 369: 1553 - 1564The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus Lower Positive End - Expiratory Pressures in patients with the Acute Respiratory Distress Syndrome. N Engl J Med 2004; 351: 327 - 36Briel M, Meade M, Mercat A, et al. Higher vs. lower positive end-expiratory pressure in patients with Acute Lung Injury and Acute Respiratory Distress Syndrome. Systematic Review and Meta-analysis. JAMA 2010; 303 (9): 865 - 873.The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301 - 1308.Papazian L, Forel J, Gacouin A, et al. Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome. N Engl J Med 2010; 363: 1107 – 1116.Shariatpanahi Z, Taleban F, Mokhtari M, et al. Ginger extract reduces delayed gastric emptying and nosocomial pneumonia in adult respiratory distress syndrome patients hospitalized in an intensive care unit. J Crit Care 2010; 25 (4): 647 - 50Raoof S, Goulet K, Esan A, et al. Severe Hypoxemic Respiratory Failure Part 2. Nonventilatory Strategies. Chest 2010; 137 (6): 1437 - 1448.Ng Gong M. Genetic epidemiology of Acute Respiratory Distress Syndrome: Implications for future prevention and treatment. Clin Chest Med. 2006 December; 27(4): 705 – x.. Reddy A, Kleeberger S. Genetic polymorphisms associated with acute lung injury. Pharmacogenomics. 2009 September; 10 (9): 1527 – 1539. Adhikari N, Burns K, Meade M O, et al. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 10, Art. No. CD004477.Gadek J, DeMichelle S, Karlstad M, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine 1999; 27 (8): 1409 - 20.Singer P, Theilla M, Fisher H, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006; 34: 1033 - 1038.Pontes-Arruda A, DeMichele S, Seth A, et al. The Use of an inflammationmodulating diet in patients with Acute Lung Injury or Acute Respiratory Distress Syndrome: A Meta-analysis of Outcome data. JPEN J Parenter Enteral Nutr 2008; 32: 596Rice T, Wheeler A, Thompson B, et al. Enteral Omega-3 Fatty Acid, gamma- Linolenic Acid,and antioxidant supplementation in Acute Lung Injury. JAMA. 2011; 306 (14): 1574 - 1581.Perkins G, McAuley D, Thickett D, et al. The B -Agonist Lung Injury Trial (BALTI). A Randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006; 173: 281 – 287.The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Randomized, placebo-controlled clinical trial of an aerosolized b 2-Agonist for treatment of Acute Lung Injury. Am J Respir Crit Care Med 2011; 184: 561 – 568.Smith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet. 2012 January; 379: 229 – 235Smith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, ranSmith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet. 2012 January; 379: 229 – 235domised controlled trial. Lancet. 2012 January; 379: 229 – 235Smith F, Perkins G, Gates S, et al. Eプect of intravenous く-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet. 2012 January; 379: 229 – 235Sud S, Friedrich J, Taccon P, et al. Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med 2010; 36: 585 – 599.Abroug F, Ouanes L, Dachraoui F, et al. An updated study-level metaanalysis of randomized controlled trials on proning in ARDS and acute lung injury. Critical Care 2011; 15: R6Jadad A, Moore R, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled clinical trials. 1996; 17 (1): 1 – 12Meduri U, Golden E, Freire A, et al. Methylprednisolone infusion in early severe ARDS. Results of a randomized controlled trial. Chest 2007; 131; 954 - 963Steinberg K, Hudson L, Goodman R, et al. Efficacy and safety of Corticosteroids for persistent Acute Respiratory Distress Syndrome. N Engl J Med 2006; 354: 1671 - 84.Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired Pneumonia. A preliminary randomized study. Am J Respir Crit Care Med. 2005; 171: 242 – 248Meduri U, Headley A, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving Acute Respiratory Distress Syndrome: a randomized controlled trial. JAMA. 1998; 280 (2): 159 - 65Olivo S, Macedo L, Gadotti I et al. Scales to asses the quality of randomized controlled Trials: A systematic review. Phisycal Therapy. 2008; 88 (2).Taylor R, Zimmerman J, Dellinger R, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004; 291 (13): 1603 – 9.Dellinger R, Zimmerman J, Taylor R, et al. Effects of inhaled nitric oxide in patients with Acute Respiratory Distress Syndrome: Results of a randomized phase II trial. Crit Care Med 1998 Jan; 26 (1): 15 - 23.Troncy E, Collet J, Shapiro S, et al. Inhaled nitric oxide in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 1998; 157: 1483 – 1488Michael J, Barton R, Saffle J, et al. Inhaled nitric oxide versus conventional therapy effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998; 157: 1372 – 1380.Payen D, Vallet B, for the Genoa group. Results of the French prospective multicentric randomized double-blind placebo-controlled trial on inhaled nitric oxide in A RDS [abstract]. Int Care Med. 1999; 25 Sl 1: 83.Mehta S, Simms H, Levy M, et al. Inhaled nitric oxide improves oxygenation acutely but not chronically in acute respiratory distress syndrome: a randomized, controlled trial. Journal of applied research in clinical and experimental therapeutics 2001; 1: 73 – 84.Park K, Lee Y, Oh Y, et al. Combined effects of inhaled nitric oxide and a recruitment maneuver in patients with Acute Respiratory Distress Syndrome. Yonsei Medical Journal 2003; 44 (2): 219 – 26.Lundin S, Mang H, Smithies M, et al. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. Int Care Med. 1999; 25: 911 – 9.Gerlach H, Keh D, Semmerow A, et al. Dose-response characteristics during long -term inhalation of nitric oxide in patients with severe Acute Respiratory Distress Syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med 2003; 167 (7): 1008 – 15.Cuthbertson B, Galley H, Webster N. Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury. Crit Care Med 2000; 28: 1736 – 41.Afshari A, Brok J, Møller A, et al. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No. CD002787.Cinel I, Opal S. Molecular biology of inflammation and sepsis: A primer. Crit Care Med 2009; 37: 291 – 304.Vincent J, Artigas A, Petersen L, et al. A multicenter, randomized, doubleblind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome. Crit Care Med. 2009: 37; 1874 – 1880.Liu K, Levitt J, Zhuo H, et al. Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury. Am J Respir Crit Care Med. 2008; 178; 618 – 623.Montgomery B, Stager M, Carrico J, et al. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985; 132: 485 – 91The national heart, blood and lung institute Acute Respiratory Distress Syndrome (ARDS) clinical trials network. Comparison of two fluidmanagement strategies in acute lung injury. N Engl J Med. 2006; 354: 2564 - 75.Ferring M, Vincent J. Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J. 1997; 10: 1297 – 300Estenssoro E, Dubin A, Laffaire E, et al. Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med 2002; 30: 2450 – 6Peter J, John P, Graham P, et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: metaanalysis. BMJ. 2008; 336; 1006 – 09Tang B, Craig J, Eslick G, et al. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and metaanalysis. Crit Care Med. 2009; 37: 1594 – 1603.http://hdl.handle.net/10818/6365159385TE0579468 Páginas.Se realizó una revisión sistemática de la literatura y meta-análisis, el objetivo fue determinar la eficacia (disminución de la mortalidad) de los tratamientos farmacológicos asociados a la terapia estándar en los pacientes que desarrollan SDRA moderado a severo cuando se compara con la terapia estándar únicamente. La conclusión fue que la adición de esteroides a una estrategia de ventilación mecánica protectora pulmonar fue asociada a una tendencia a reducir la mortalidad, además la nutrición enteral inmunomoduladora mostró una pequeña pero significativa disminución de la mortalidad. Por el contrario, la adición de beta 2 agonistas parece incrementar el riesgo de muerte.spaUniversidad de La SabanaEspecialización en Medicina InternaFacultad de MedicinaUniversidad de La SabanaIntellectum Repositorio Universidad de La SabanaAparato respiratorio-EnfermedadesTerapia respiratoriaFarmacologíaTerapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados.bachelorThesisTesis de especializaciónpublishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/access_right/c_abf2LICENSElicense.txtlicense.txttext/plain; charset=utf-8498https://intellectum.unisabana.edu.co/bitstream/10818/6365/2/license.txtf52a2cfd4df262e08e9b300d62c85cabMD52Carlos Alfonso Vélez Álvarez (Carta).pdfCarlos Alfonso Vélez Álvarez (Carta).pdfapplication/pdf1044185https://intellectum.unisabana.edu.co/bitstream/10818/6365/5/Carlos%20Alfonso%20V%c3%a9lez%20%c3%81lvarez%20%28Carta%29.pdf8603a5933485b845587bf14732a565aeMD55ORIGINALCARLOS ALFONSO VELEZ (T)FINAL.pdfCARLOS ALFONSO VELEZ (T)FINAL.pdfVer documento en PDFapplication/pdf1230773https://intellectum.unisabana.edu.co/bitstream/10818/6365/3/CARLOS%20ALFONSO%20VELEZ%20%28T%29FINAL.pdf634edc3fe42712308d3a9eb777d7f93fMD53TEXTCARLOS ALFONSO VELEZ (T)FINAL.pdf.txtCARLOS ALFONSO VELEZ (T)FINAL.pdf.txtExtracted Texttext/plain70https://intellectum.unisabana.edu.co/bitstream/10818/6365/4/CARLOS%20ALFONSO%20VELEZ%20%28T%29FINAL.pdf.txt17bb03d156e9130ba507d1851a2d3bdeMD5410818/6365oai:intellectum.unisabana.edu.co:10818/63652019-08-13 16:21:38.766Intellectum Universidad de la Sabanacontactointellectum@unisabana.edu.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

Terapias farmacológicas en adultos con síndrome de dificultad respiratoria aguda (SDRA): Revisión sistemática y meta-análisis de ensayos clínicos controlados.

Publicaciones similares